Amble
Amble is a telehealth platform offering compounded GLP-1 medications with a commitment-tier pricing model built around predictability. The headline feature is flat-rate pricing across all dose levels — patients pay the same monthly rate regardless of where they are in titration — combined with price breaks that deepen as commitment length increases, from one-month to twelve-month plans.
Overview
- Consultation Model
- Async Telehealth
- Headquarters
- United States
- Shipping
- 3-5 business days
- Lab Testing
- No
- Prescriber Info
- licensed physicians, with certain states requiring a video or phone visit before approval.
Pros
- Flat-rate pricing removes dose-escalation cost uncertainty
- 12-month plan at $135/mo is highly competitive for long-term patients
- Four commitment tiers give flexibility (1, 3, 6, 12 months)
- Unlimited 24/7 support included
- Free expedited delivery
- Lifestyle coaching integrated into the program
Cons
- Pricing may increase after four months at higher doses
- Compounded tirzepatide not available in all 50 states (~45 states)
- No insurance accepted
- Compounded GLP-1s are not FDA-approved; face active FDA enforcement pressure
- Some states require video/phone visit before approval (may add friction for fully async-seeking patients)
- Auto-subscription model
Pricing
| Medication | Dose | Price | Billing |
|---|---|---|---|
| semaglutide | standard | $99 | monthly |
| tirzepatide | standard | $179 | monthly |